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INTRODUCTION 
 Opioids have been used in the treatment of pain for thousands of years. 
The opioids contains 20 alkaloids. Opium means juice, from Greek word. 
Morphine is the prototype drug and named after Greek God of dreams, 
Morpheous.  
 Morphine was used in American civil war in 1869. In 1950. Opioid 
anesthesia  came with advent of cardiac surgery. However, because of 
incomplete suppression of stress response, hypotension, awareness during 
anesthesia and increased fluid and blood requirement and need to ventilate post 
operatively, limited its use. 
 Opioid refers to drugs derived from opium both natural and synthetic. 
Narcotic refers to morphine and morphine-like analgesics. 
 Morphine can be used as spinal analgesic, Epidural analgesic as shown 
by Behar et al. Despite the high efficacy, it was not widely used because of 
early reported high incidence of respiratory depression and somnolence. It was 
due to high doses, rather than route of administration. 
 Gwirtz and associates recently reported high patient satisfaction and low 
incidence of side effects and complication of morphine over 6000 patients. 
 Therefore, this study has been undertaken to analyze the effect of 
intrathecal morphine as more cost effective analgesic when compared to 
Multimodal analgesia. 
 
AIM OF STUDY 
 To evaluate the effect of preservative free morphine 0.5 mg 
administered intrathecally, on intraoperative anaesthetic requirement and 
postoperative analgesia in patients undergoing laparotomies under general 
anesthesia compared with multimodal analgesia, during the Ist 24 hours of  
postoperative period. 
The following parameters were studied 
 1. Intra operative hemodynamics 
 2. Post operative pain score and analgesic requirement 
  3. Post operative hemodynamics 
 4. Complications: both  intraoperative and postoperative period 
 
 
 
 
 
 
 
SPINAL ANAESTHESIA 
 Spinal anesthesia is a form of central neuraxial block in which a 
temporary interruption of impulse  transmission is achieved following injection 
of local anaesthetic and or adjuvant solutions into the subarachnoid space. 
 Spinal anaesthesia is one of the most frequently employed methods of 
regional anaesthesia. 
Anatomy 
 The vertebral canal extends from the foramen magnum to the sacral 
hiatus. It is formed dorsal spine, pedicles and laminae of successive vertebra (7 
cervical, 12 thoracic, 5 Lumbar and 5 sacral). The vertebral are held together 
by a series of overlapping ligaments, ligamentum flavum, interspinous 
ligament, supraspinous ligament and the intervertebral disc. 
 The spinal cord, a direct continuation of the medulla oblongata begins at 
the upper border of the atlas and terminates distally in the conus medullaris. 
The distal termination, because of the differential growth rates between the 
bony vertebral canal and central nervous system varies from L3 in the infant, to 
the lower border of L1 in the Adult. 
 Surrounding the spinal cord in the bony vertebral column are three 
membranes (from within to the periphery) the piamater, arachnoidmater and 
duramater. The piamater is highly vascular membrane that closely invests the 
spinal cord. The arachnoidmater is a delicate non-vascular membrane closely 
attached to the outer most duramater. 
 Between the two inner most membranes is the subarachnoid space. In 
this space are the cerebrospinal fluid (CSF), spinal nerves, blood vessels that 
supply the spinal cord and the dentate ligaments. Although the spinal cord ends 
at the lower border of L1 in adults, the subarachnoid space continues up to S2. 
The outer membrane in the spinal canal is the longitudinally organized 
fibroelastic membrane, the duramater. This layer is the direct extension of the 
cranial duramater and extends as spinal duramater from the foramen magnum 
to S2, where the filum terminale (an extension of the piamater beginning at the 
conus medullaris) blends with the periosteum of the coccyx. There is a 
potential space between the duramater and arachnoid, the subdural space, 
which contains only small amount of serous fluid to allow the dura and 
arachnoid move over each other. Surrounding the duramater is epidural space, 
which extends from the foramen magnum to the sacral hiatus. Immediately 
posterior to ligamentum flavum is the interspinous ligament, extending from 
the external occipital protuberance to the coccyx, posterior to these structures is 
the supraspinous ligament. 
 Lumbar puncture is routinely done below the L2 vertebra down to the  
L5 - S1 interspace to avoid damaging the spinal cord that ends at the lower 
border of L1 vertebra in adults. 
 
PHYSIOLOGY OF SUBARACHNOID BLOCK 
Cerebrospinal Fluid 
 The cerebrospinal fluid is an ultra filtrate of blood and plasma with 
which, it is in hydrostatic and osmotic equilibrium. It is clear, colourless fluid 
found in the spinal and cranial subarachnoid space and in the ventricles of the 
brain. The average volume in the adult ranges from 120 - 150 ml, of which 35 
ml is in the ventricles, 25 ml is in the cerebral subarachnoid space and 75 ml is 
in the spinal subarachnoid space. It is secreted by the choroid plexus of lateral 
ventricles at a rate of 0.3 - 0.4 ml/minute. 
Physical characteristics of Cerebrospinal Fluid 
 pH    7.4 
 Specific gravity  referred to H2O 
 at body temperature  1.007 
 at 4°C    1.0003 
 Density   1.0003 g/ml 
 Baricity   1.000 
 Pressure   8 - 12 mm Hg / 70-80 mm H2O 
 Cells    3-5 / cu.mm 
 Proteins   20 mg / dl 
 Glucose   45 - 80 mg/dl 
 The Cerebrospinal fluid plays an important role in spinal anesthesia as 
media for dispersion of the local anesthetic drug to the spinal nerve. An 
important factor determining the spread of drugs in the subarachnoid space is 
the specific gravity of the injected solution compared to  that of C.S.F. 
 In our study  preservative free morphine is diluted with 0.9% Nacl and 
injected intrathecally, which is isobaric to C.S.F. The morphine injected 
intrathecally is diluted by C.S.F and there for original concentration is of less 
important than the actual mass of drug. Spread is also determined by the 
baricity of the injected solution. 
 Baricity is a ratio comparing the density of any solution(morphine) at 
specified temperature to the density of CSF at the same temperature. 
Contraindications for subarachnoid block 
 An absolute contraindication is patient refusal. 
Other contraindications are 
 Local sepsis 
 Uncorrected coagulopathy 
 Uncontrolled blood loss / shock 
 Fixed cardiac output states 
 Documented allergy to study drug (Morphine, if any) 
 Raised intracranial pressure 
 Active neurological disease 
 Major spine deformities / previous surgery on the spine 
 Severe cardiac disease 
Subarachnoid block technique 
 First step in the successful conduct of spinal anesthesia is proper patient 
selection. This is accomplished by preanesthetic evaluation of the patient 
through history, physical examination, laboratory data and communication with 
the patient and surgical colleagues about details of the procedure. 
Premedication is Tab. Alprazolam 0.25 mg and Ranitidine 150mg P.O., 2 hours 
before surgery is given. 
 Patient is explained the procedure previous day and visual analog score 
is also explained to him preoperatively. 
 IV access is obtained through 16G intravenous cannula  preloading with 
balanced salt solution like 0.9% Nacl or lactated Ringer  500 ml is 
administered. 
Procedure 
 The subarachnoid block consists of 4 p's viz preparation, position, 
projection and puncture. 
Preparation 
 Preparation of the equipment and drug is essential for performing a 
subarachnoid block. The choice of drug is based on the duration of block 
desired, the surgical procedure and patient variables 25G Quinckie - Babcock 
spinal needle is selected, small size is said to prevent postdural puncture 
headache (PDPH). 
Position 
 The patient was turned right laterally. 
Projection and Puncture 
 The patient back is painted with betadine and spirit with 2 times each, 
then dry painting with sterile gauze is done. Then fenestrated draping is done. 
Identify the midline spines from above downwards. 
 A line drawn from highest point of iliac crest passes through either 
spinous process of L4 or L4 - L5 interspace. Traditionally the midline approach 
with patient in lateral decubitus is most popular. After infiltrating with local 
anesthetic at  L3 - L4 interspinous space, the spinal needle is held like a dart and 
advanced keeping the bevel parallel to the longitudinal dural fibres so that it 
separate the fibres rather than cut it. The needle is advanced slightly in 
cephalad direction with the long axis of the vertebral column. A characteristic 
change in resistance occurs as the needle traverses the supraspinous ligament, 
interspinous ligament, ligamentum flavum and pierces the arachnoid, which 
becomes quite recognizable as experience is gained. 
 The stylet is then removed and appearance of cerebrospinal fluid at the 
hub of the needle confirms the correct position of the needle tip. The morphine 
sulphate comes as preservative free as 10 mg / ml in 1 ml ampoule. It is diluted 
with sterile normal saline to 10 cc so that each ml contains 1 mg/ml. Then  ½ 
cc taken from this, diluted to '1' cc with normal saline taken in sterile cup, so 
that each ml contains 0.5 mg morphine. 
 This 1 ml of morphine (0.5 mg) is injected intrathecally without 
barbotage. After injecting morphine, patient was turned supine. 
METHODS OF PAIN MEASUREMENT 
 Pain is a personal, subjective experience influenced by cultural learning, 
the meaning of the situation, attention and other psychological variables. 
Melzack suggested a three dimensional view of pain which comprises of 
sensory-discriminative, motivational-affective, cognitive-evaluative 
components. 
Methods of Pain Measurement include 
1.  Verbal rating scale 
2.  Visual analogue pain scale 
3. Mc Gill pain Questionnaire 
4.  The Descriptive Differential Scale 
Visual Analogue Pain Scale  
Advantages 
1.  Simple, efficient, minimally intrusive measure of pain intensity 
2.  Widely used in clinical as well as research settings 
Disadvantages 
1.      Bias of expectancy for change and reliance on memory  
2       It is an assumption that pain is a unidimensional experience 
INTRATHECAL OPIOIDS 
History 
             Pert CB and Snyder SH. first identified opiate receptors in the central 
nervous system in 1973. Subsequently, large populations of these receptors 
were localized in the dorsal horn of the spinal cord. In 1976, Yaksh TL and 
Rudy TA performed animal studies and demonstrated the ability of intrathecal 
opioids to produce analgesia. In 1979, Wang and colleagues reported pain 
relief using intrathecal morphine in cancer patients and in the same year, Behar 
et al achieved the same result by injecting the drug into the epidural space. 
Neuraxial opioids 
             Placement of opioids in the epidural or subarachnoid space to manage 
acute or chronic pain is based on the knowledge that Opioid receptors 
[principally mu receptors] are present in the substantia gelatinosa of the spinal 
cord [Cousins and Mather, 1984]. Analgesia produced by neuraxial opioids, in 
contrast to intravenous [IV] administration of opioids or regional anaesthesia 
with local anaesthetics, is not associated with sympathetic nervous system 
denervation, skeletal muscle weakness, or loss of proprioception. Analgesia is 
dose related. 
Spinal opioid receptors - location 
             Opioid receptors are synthesized in the cell body of the sensory neuron 
and are transported in both the central and peripheral directions. In the spinal 
cord, opioid receptors are found in the dorsal horn in the terminal zones of C 
fibers primarily in laminae I of the substantia gelatinosa. Spinal opioid 
receptors are 70% mu, 24% delta and 6% kappa type. 
Mechanism of Action 
             Opioids act as agonists at stereo specific opioid receptors at 
presynaptic and postsynaptic sites in the central nervous system (principally the 
brain and spinal cord) and outside the CNS, in peripheral tissues. 
              The principal effect of Opioid receptor activation is a decrease in 
neurotransmission by presynaptic inhibition of neurotransmitter (acetylcholine, 
dopamine, norepinephrine, substance P) release, although postsynaptic 
inhibition of evoked activity also occurs. The biochemical events following 
opioid receptor activation are characterized by increased potassium 
conductance (leading to hyperepolarisation), calcium channel activation, or 
both, which produced an immediate decrease in neurotransmitter release. 
       Activation of opioid receptors in the primary afferent neurons may 
either directly decrease neurotransmission or inhibit the release of excitatory 
neurotransmitters such as substance P. 
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Neuraxial Opioids 
       Based on the knowledge, Opioid receptors (principally mu receptors) are 
present in the substantia gelatinosa of the spinal cord. 
       In contrast to intravenous administration of opioids (or) regional 
anaesthesia with local anaesthetics, analgesia produced by neuraxial opioids is 
not associated with sympathetic nervous system denervation, skeletal muscle 
weakness or loss of proprioception. Analgesia is dose related and is specific for 
visceral rather than somatic pain and neuraxial opioid  decreases the minimum 
alveolar concentration (MAC) of the volatile anaesthetics. 
Spinal Opioid Receptors - Location 
 Opioid receptors were synthesized in the cell body of the sensory neuron 
and were transported in both the central and peripheral directions. In the spinal 
cord, Opioid receptors are found in the dorsal horn in the terminal zones of C 
fibers primarily in lamina I of the substantia gelatinosa. Spinal opioid receptors 
are 70% mu, 24% delta and 6% kappa. 
Mechanism of Action 
 Spinal opioids act at nerve synapses either presynaptically [as 
neuromodulators] or postsynaptically [as a neurotransmitter]. Stimulation of 
presynaptic receptors is associated with hyperpolarization of the terminal and 
reduced substance P release. This relates primarily to inhibition of voltage 
gated calcium channels. Postsynaptic membranes contain opioid receptors 
linked to potassium channels. Stimulation of these receptors enhances outward 
flow of potassium thereby stabilizing the membrane, making it less sensitive to 
neurotransmitters. Second messengers [G proteins] carry out these actions. 
 With the injection of an opioid into the CSF, a reservoir of drug is 
created that passively diffuses into the dorsal horn of the spinal cord where it 
exerts its action by binding to opioid receptors. 
 
Pharmacokinetics 
 The onset of analgesic effect following intrathecal administration of an 
opioid is directly proportional to the lipid solubility of the drug, whereas the 
duration of effect is longer with more hydrophilic compounds. Opioids placed 
in the epidural space undergo significant systemic absorption and passage into 
the subarachnoid space. Vascular absorption after intrathecal administration of 
opioids is insignificant. Cephalad movement of opioids in the CSF is dependent 
on lipid solubility. Lipid soluble opioids like fentanyl are limited in the 
cephalad migration by uptake into the spinal cord, while hydrophilic opioids 
like morphine remain in the CSF for transfer to more cephalad locations. 
 Loss of analgesia after intraspinal injection primarily results from 
clearance of drug from the site of action. Intrathecal opioids were eliminated by 
diffusion along the neuraxis and vascular absorption. It is not yet established 
what role metabolism plays in the termination of action of intrathecal opioids. 
Tolerance 
 Decrease in effect over time to a given dose of drugs has been 
demonstrated with intrathecal opioids. There is good evidence in support of the 
glutamate receptor of the NMDA type to be involved in the mechanism of 
tolerance. 
Benefits 
• Long lasting post operative analgesia after a single injection 
• Precise and reliable placement of low concentration of drug near its site of 
action. 
      The principle disadvantage was lack of titrability and need to either repeat 
the injection or consider other options when the analgesic effect of the initial 
dose wanes. Nevertheless, common clinical experience is greatly diminished.  
Can be satisfactorily managed by other modalities. 
Side Effects 
1. Pruritus 
 Pruritus is the most common side effect and is more likely to be 
localized to the face, neck or upper thorax, often elicited only after direct 
questioning, particularly in obstetric patients, due to the interaction of estrogen 
with opioid receptors. It is due to cephalad migration of the opioid in CSF and 
subsequent interaction with opioid receptors in the trigeminal nucleus. 
Naloxone, an opioid antagonist is effective in relieving pruritus. 
2. Urinary Retention 
 It is  common in young males and with spinal and epidural 
administration than after IM or IV administration. 
 It is most likely due to interaction with opioid receptors located in sacral 
segment of the spinal cord and inhibition of sacral parasympathetic nervous 
system outflow, which causes detrusor muscle relaxation and increase in 
bladder capacity, leading to urinary retention and was readily reversed with 
Naloxone. 
3. Depression of ventilation 
 This is the most serious side effect of neuraxial opioids which may 
occur within one minute or may be delayed for hours, requiring intervention. 
 Early depression of ventilation occurs within 2 hours of neuraxial 
injection of opioid and results from systemic absorption of the lipid soluble 
opioids. Eg. Fentanyl, Sufentanil. 
 Delayed depression of ventilation occurs more than 2 hours and reflects 
cephalad migration of the opioid in the CSF and subsequent interaction with 
the opioid receptors in the ventral medulla. Eg. Morphine. 
Factors that increase the risk of depression of ventilation. 
High opioid dose 
Low lipid solubility of opioids 
Concomitant administration of parenteral opioids 
Lack of opioid tolerance 
Advanced age 
4.  Sedation - Dose related particularly with morphine. 
5. CNS excitation 
 Tonic skeletal muscle rigidity resembling seizure activity occur 
following large IV doses of opioids but rarely with neuraxial administration. 
Cephalad migration in the CSF and interaction with non-Opioid receptors in 
the brain stem (or) basal ganglia is the most likely explanation, inhibition of the 
inhibitory neurotransmitters. 
6. Viral reactivation 
 Reactivation of herpes simplex labialis may occur 2-5 days after 
epidural administration. 
7. Neurotoxicity 
 Animal and human studies have not demonstrated neurotoxicity with 
any of the commercially available preservative free opioid agents administered 
by the subarachnoid route. 
Advantages of Intrathecal Morphine 
 1. Ease of administration 
 2. Single shot technique 
 3. No need of costly equipment to administer it 
 4. Definitive end point of success, like aspiration of CSF 
Disadvantages 
 1. It causes delayed respiratory depression  
 2. Need for monitoring at PACU / High dependency Unit 
 3. Lack of titrability 
 4. Postdural Puncture headache (PDPH) 
Morphine Sulfate 
 It is belongs to phenanthrene alkaloids. It is a prototype of drug to which 
all the Opioid analgesics potency are compared. 
 Chemically it has a rigid five ring structure conforms to a "T" shape, 
with a phenyl piperidine ring forming a cross bar and a hydroxylated aromatic 
ring in the vertical axis. 
 Morphine has major effects in the CNS and the gastrointestinal systems, 
but other systems are also affected. 
Analgesia 
 Morphine act selectively at µ1, µ2 opioid receptors on neurons that 
transmit and modulate nociception, leaving other sensory modalities and motor 
functions intact. 
 At the spinal cord level, morphine acts presynaptically on primary 
afferent receptors to decrease the release of substance p and hyperpolarizes 
postsynaptic neurons in substantia gelatinosa of dorsal spinal card to decrease 
afferent transmission of nociceptive impulses. Spinal morphine analgesia is 
mediated by µ2 opioid receptors. 
 Supraspinal opioid analgesia originates in the periaqueductal grey matter 
(PAG), the locus ceruleus (LC), and nucleus within medulla, the nucleus raphe 
magnus (NRM). 
Other Side Effects 
 1. Cognitive and five motor impairment showing of E.E.G. activity. 
Morphine inhibits me release of several pituitary hormones both 
directly and indirectly.  
 2. Respiratory depression: It products respiratory depression and 
shift right ward and decrease the slope of ventilatory response to 
CO2 curve. 
 3. Cough 
  It suppresses cough reflex by acting at medullary cough centre. 
 4. Nausea and vomiting 
 It is most frequency side effect of morphine due to stimulation of 
chemoreceptor trigger zone (CTZ) in medulla, pharynx, GI tract 
and have rich opioid receptors. 
  It delays gastric emptying. 
 5. Urinary retention: Seen after systematic and spinal morphine 
administration but is reversible with naloxone. 
Histamine release 
 Occurs in a dose dependant manner. 
Cardiovascular effects 
 It can produce arteriolar and venous dilatation decreased peripheral 
resistance and inhibition of baroreceptor reflexes. It has central sympatholytic  
action and leads to hypotension in who have high sympathetic tone. 
 It can cause bradycardia due to both sympatholytic and 
parasympathothimetic actions. I.v 0.01 to 0.2 mg/ kg Dosage is  used  for 
Premedication for balanced anesthesia. 
Pharmacokinetics 
 pH 7.9; percentage non ionized at pH 7.4 ; protein binding 35%.It is 
hydrophilic in nature 35% protein bound and mostly to albumin. Morphine may 
be administered orally, subcutaneously, intrathecally and intravenously. 
Hepatic clearance is high. It has clearance of 1050 ml/min 
 Poor penetration in CSF is due to  
 a. Poor lipid solubility 
 b. High degree of ionization at physiological pH  
 c. Protein binding 
 d. Rapid conjugation with glucuronic acid. 
Metabolism 
 The principal pathway of metabolism is conjugation with glucuronic 
acid in hepatic and extra hepatic sites especially kidneys. Its metabolites one 
morphine 6-glucoronide and morphine - 3 - Glucuronide when former is active 
and later is an inactive metabolite. 
 Duration of action of Morphine peak analgesic effects in 20 to 60 
minutes that last for 12 hrs when dosing range from 0.25 mg to 1 mg given 
intrathecally but doses in the range of 0.25 m to 0.5 mg generally maintain 
analgesic efficacy while minimizes ventilatory depression. 
REVIEW OF LITERATURE 
Identification of opiate receptors in the brain and spinal cord and the 
role of morphinomimetic substances in the mechanisms of pain perception have 
led to the use of intrathecal opioid in animals and man for the relief of pain. 
Intrathecal Opioid receptors and Analgesia 
 Pert CB and Sinder SH [1973] demonstrated the presence of opioid 
receptors ion high density in the dorsal horn of the spinal cord. 
Yaksh TL and Rudy TA53 [1976] published a study on the 
effectiveness of intrathecal morphine for relief of experimental pain in rats. 
This report initiated a series of trails in main. 
Behar M et al1 [1979] reported the first effective use of epidural opioids 
in human while Wang JK et al2 [1979] reported the first controlled study of 
intrathecal opioids in human. They demonstrated that small doses of morphine 
given intrathecally or extradurally produced long lasting relief of chronic and 
post operative pain in man. The use of these methods spread rapidly and 
became clinically accepted long before data from controlled studies were 
published. 
Crawford JS45 [1980] claimed that spinal opioids act predominantly on 
the brain. 
Willer JC and Bussel B52 [1980] and Maruyama Y et al [1980] 
suggested a selective spinal analgesic effect in humans.  
Willer JC and Bussel B52 [1980] and Yaksh TL [1981] suggested that 
opioids act on presynaptic and postsynaptic receptors in th4e substantia 
gelatinosa of spinal cord dorsal where they inhibit neurone cell excitation. 
Nicol et al [1991] studied densities of various drugs used intrathecally. 
They used 5% glucose as a vehicle for use as a hyperbaric solution along with 
opioids. They concluded that all drugs dissolved in 5% glucose were 
hyperbaric in comparison with CSF at room and body temperature. 
ANALGESIC EFFECT OF INTRATHECAL MORPHINE 
JA Eandi, RW De vere White retrospectively analysed the analgesic 
efficacy and surgical out come of single dose intrathecal long acting morphine 
(0.25 – 0.5mg) and postoperative ketrolac who underwent radical retropubic 
prostatectomy (RRP). They conducted single preoperative injection of 
intrathecal morphine sulphate combined with rescue I.V. Ketrolac. They 
concluded that IT Morphine results in effective analgesia in the post-operative 
period , diminished supplemental narcotic requirement and high patient 
satisfaction.  
Jean-Michel Devys,Anne Mora, Benoit Plaud et al (2003) studied the 
analgesic effect and sideeffects produced by IT Morphine 0.4 mg in 60 adult 
patients undergoing major abdominal surgery. The control group received 
PCA-Morphine. VAS scores, supplemental analgesia consumption, patient 
satisfaction, arterial saturation, respiratory rate, nausea, vomiting and Pruritis 
were studied. VAS scores were lower in the IT morphine group for the first 48 
hours, both at rest and during coughing. No patient had a respiratory rate < 10 
in both the groups but IT morphine group needed supplemental oxygen to 
maintain SaO2. Nausea and Vomiting was more in the IT morphine group. 
ASK Kwan, BB.Lee, T.Brake et al (1997) studied the effect of 
addition of 0.2 mg of preservative free morphine 0.2 mg to 2.2 ml of 
hyperbaric bupivacaine (2.6 ml)SsS in patients undergoing hip surgeries. Post-
operative VAPS score was used to assess pain every 2 hours for the first 24 
hour period. Time to first rescue analgesia demand was noted. The duration of 
analgesia was defined as time from performance of SAB to the time when 
patient made first request for analgesia. Respiratory rate, sedation scores, 
Nausea, vomiting, Hemodynamics and other complications were monitored. 
The morphine group had significantly lower VAPS score when compared to 
control group. There was no incidence of hypopnoea or hemodynamic 
instability. Sedation scores were within acceptable range. They concluded that 
IT morphine provides excellent post-operative analgesia for the first 48 hours 
with low propensity to side effects. The reported optimal analgesia dose 
appears to lie between 0.3 mg and 1.0 mg, while significant respiratory 
depression occurs with doses of 0.8 to 1.0 mg. 
Gwirtz KH,10 Young JV, Byers RS, Alley C, Levin K, Walker SG, 
Stoelting RK published a retrospective study on the safety and efficacy of 
intrathecal opioid analgesia for acute postoperative pain over a period  seven 
years for 5969 surgical patients at Indiana University Hospital undergoing  
major urologic, orthopedic, general/ vascular, thoracic, and non-obstetrical 
gynecologic surgery. A scale of 1-10 was used to quantify each patient's 
satisfaction with analgesia. The incidence of side effects, complications, and 
naloxone usage was also recorded and tabulated. They concluded intrathecal 
opioid analgesia was used to control acute postoperative pain on nearly 6000 
patients, resulting in a high degree of patient satisfaction and a low incidence of 
side effects and complications. Side effects were minor and easily managed. 
Pruritus was the most common (37%). Respiratory depression was the least 
common (3%), easily detected by nursing observation, never life threatening, 
and always responsive to treatment with naloxone. There were no deaths, nerve 
injuries, central nervous system infections, or naloxone-related complications. 
Kirson.L.E,GoldmanJM, et al8  studied 30 patients undergoing 
lidocaine spinal anesthesia for transurethral resection of the prostate (TURP) 
were studied to evaluate the effectiveness of low-dose intrathecal morphine 
(ITM) for postoperative analgesia. In a double-blinded fashion, groups of ten 
patients received either 0.1 mg morphine, 0.2 mg morphine, or placebo (control 
group) intrathecally with lidocaine 75 mg. Standard postoperative analgesics 
were available to all patients. Patients receiving 0.1 mg or 0.2 mg morphine 
reported significantly less postoperative pain as assessed by an inverse 
numerical visual pain scale and required significantly fewer postoperative 
analgesic interventions than the control group. There was no difference 
between the 0.1 mg ITM and 0.2 mg ITM groups with regard to severity of 
postoperative pain or analgesic requirements. The incidence of nausea and 
vomiting was significantly higher in the group receiving 0.2 mg ITM than in 
the control group. Six patients (60%) in the 0.2 mg ITM group, two patients 
(20%) in the 0.1 mg ITM group, and one patient (10%) in the control group 
experienced nausea and vomiting. No clinically evident respiratory depression 
occurred in any of the subjects. The authors conclude that administration of 0.1 
mg or 0.2 mg of morphine intrathecally is effective in reducing postoperative 
pain following TURP and that 0.1 mg ITM is not associated with nausea and 
vomiting. 
T.K. Abboud, A Pror6; from the university of southern California 
studied the effect of  mini dose intrathecal morphine for relief of post caesarean 
pain. Group I received 0.25mg IT morphine. Group – II received 0.1mg IT 
morphine combined with Bupivacaine. Group III received 8mg subcutaneous 
morphine. They concluded that in Group I & II patients post op analgesia was 
27.7+ 4.0 hrs and 18.6 + 0.9hrs respectively. Group III needed an analgesic 
within 3 hrs of spinal anaesthesia and respiratory depression was more in 
Group III. 
 John R. Gray, Glenn A. Fromme showed that post operatively 
analgesic duration following post thoractomy after intra morphine in the 
lumbar area 10ug/kg morphine either in dextrose hyperbaric or with normal 
saline (Isobaric) showed that duration of analgesic was longer with morphine in 
normal saline group than in hyperbaric group (P<0.04). 
 Ganesh A, K.M.A. Cucchiaro studied the effect of low dose (4-
5μg/kg) intrathecal morphine for post operative pain management after various 
surgical procedures in children. They had shown that median maximum pain 
score using FLACC score and numeric verbal rating scale was ‘0’. Mean time 
for first rescue opioid was 22.4+16.9 hours. Nausea or vomiting, Pruritis and 
urinary retention was 32%, 37% and 6% respectively. 
 Nordberg G. Heduer T, Dalhlstrom B (1984) studied the 
pharmacokinetic aspects of  intrathecal morphine analgesia in 15 patients 
undergoing thoractomy. The study indicates the significant pharmacokinetic 
parameter related to the long duration of analgesia after intrathecal  morphine 
administration probably is the high CSF concentration found since the rate of 
elimination from CSF is similar to what is reported for morphine in plasma. 
 Andrew et al (2000) studied the efficacy and safety of low dose ITM 
(Intrathecal Morphine) for postoperative analgesia in children and 
demonstration that ITM in pediatric population can provide safe and 
dependable period of analgesia. The average time for any patient requiring 
opioid administration (Parental or oral) was approximately 8 hours. 
 Kirson LE, Goldman JM, Scover RB  did a double blind study in 30 
patients undergoing TURP. In a double blinded fashion groups of 10 patients 
received either 0.1mg morphine, 0.2mg (ITM) morphine placebo patients 
receiving 0.1mg or 0.2mg (ITM)morphine reported significantly less post 
operative pain as assessed by an universal numerical visual pain scale and 
required significantly fewer postoperative analgesia. 
 Kwan As, Lee BB, Brake T studied the efficacy of ITM for 
postoperative analgesia in Chinese patients undergoing surgery to repair 
fractured hips. The results show the median pain free period in prolonged (i.e. 
16-24 hrs) in morphine group compared with control group (2-24 hrs).   
 Gwirtz et al10 studied the efficacy and safety of intrathecal morphine 
analgesia for acute postoperative pain, and showed that there is a higher degree 
of patient satisfaction and low incidence of side effects and complications.   
Complications of intrathecal opioids 
 Glynn CG et al48 [1979] and Davies GK et al46 [1980] reported 
respiratory depression following spinal morphine. 
 Glynn CG al [1979] reported a respiratory depression with rostral 
spread of spinal opioids. He noted a delay of upto 11 hours before onset of 
respiratory depression following spinal morphine. 
 Jones RDM20 [1980] reported that naloxone was effective for reversing 
such respiratory depression without reversing analgesia. 
 Reiz and Westberg [1980] and Yaksh TL53 [1981] and Samii J, 
Chanin M and Viars P [1981] reported adverse reactions such as Pruritis and 
urinary retention after intrathecal administration of opioids. 
 Oyama T [1980] observed that Pruritis did not occur following 
intrathecal  endorphin. 
 Bromage PR et al42 [1982] suggested that pruritus may be due to 
alterations in sensory modulations following opioid spread over the spinal cord 
to the brain. They also found naloxone to be effective in the control of pruritus 
in some cases. 
 Roscow CE et al [1982] reported pruritus associated with spinal opiodis 
but was a opinion that it was unlikely to be due to histamine release since 
pruritus occurred with fentanyl which does not cause systemic release of 
histamine. 
 Lam et al [1983] reported that delayed respiratory depression does not 
occur after epidural fentanyl which has lipophilic properties similar to 
pethidine. 
 Cousins MJ and Mather LE al [1984] suggested that the pruitus was 
unlikely to be due to the preservatives in the opioid since it occurs also with 
preservative free preparations. 
  
 
MATERIALS AND METHODS  
 This study was conducted at Government General hospital, Madras 
Medical College General between July 2008 to A September 2008 at  General 
surgical  operation theatre. 
1. The study was done after getting Institutional Ethical committee 
approval  
2. Written informed consent were obtained from all patients included in the 
study. 
 All patients were explained preoperatively about the procedure and 
visual analog scale (Pain score) 10 cm scale so that it can be effectively used 
by the patient during the postoperative period. 
Inclusion Criteria Exclusion Criteria 
1. A.SA I, II, III patients 1. Patient refusal 
2. Those patients who are 
undergoing upper and bower 
abdominal Surgeries 
2. Contraindication to 
subarachnoid block 
 3. Hypersensitivity to study group 
 4. Difficult airway MMS** >3 
 5. Hepatic and renal dysfunction 
 6. Not meeting inclusion criteria 
 
MMS- Modified mallampatti score. 
  
 50 patients of ASA physical status I, II and III  undergoing both upper 
and lower abdominal surgeries like partial Gastrectomy, open cholecystectomy,  
incisional hernia, hemicolectomy and laparotomy under general anesthesia.  
 
 The patients are categorized into one of two groups. 
 
 Group M - Morphine - Study Group 
 Group C - Control Group 
 All patients were assessed preoperatively using standard protocols and 
underwent preoperative evaluation. 
 All patients received Premedication T.alprazolam using T.Ranitidine 
150 mg P.O. the night before surgery and on the day of surgery 2 hours before 
operation P.O. with sips of water. 
 Preservative free Morphine sulphate comes in two strengths 15 mg / ml 
and 10 ml / ml ampoule manufactured by verve health care Ltd. We used 10 
mg/ml of morphine sulphate (Vermor - 10). This was taken in sterile 10 ml 
syringe mixed with sterile Normal saline by the incharge Anaesthesiologist 
uninvolved in the administration of Subarachnoid block or in further conduct of 
the study . This solution was isobaric to cerebrospinal fluid . 
 In the OT,  patients  were hooked on to monitors like E.C.G., pulse 
oximetry and Non invasive BP. After Baseline evaluation and recording of 
baseline data, Two 16G large IV cannula was started in both forearms. 500 ml 
of balanced salt solution was administered as preload. The patient was turned  
to right lateral position. Back was painted with antiseptic solution  and draped. 
Morphine is taken in 0.5 mg diluted to 1 cc with Normal saline. Subarachnoid  
block was performed with 25G Quinckie Babcock spinal needle at the L3-L4 
ISS and after confirming free flow of CSF , the study drug ie:1 ml of 
preservative free morphine 0.5 mg, was administered with due precautions. 
Then patient was assumed post-spinal supine position. The patient was 
observed for 10 minutes  before induction of general anaesthesia to look for 
any immediate untoward events. 
 After preoxygenation  with 100% oxygen (O2) for 5 minutes.   
 GA was administered composed of inj. Glycopyrrolate 10µg /kg + 
Fentanyl 2µg/kg i.v., and  Induction with inj. Thiopentone sodium 5 mg / kg 
i.v, then muscle relaxant i.v Vecuronium 0.12 mg/kg was given and mask 
ventilation done with oxygen 50% with Nitrous oxide 50% with volatile agent  
isoflurane1%. If airway difficulty is expected (MMS ≥ 3), then  
suxamethonium was used for intubation. 
 Laryngoscopy was done and intubated with 8 or 8.5 mm cuffed 
Endotracheal tube orally for male patients and 7 or 7.5 mm orally in female 
patients. Bilateral air entry was checked, tube was fixed, and cuff inflated. 
 All patients were catheterized by operating surgeon to monitor urine 
output. Then vitals were recorded every 5 minutes until the end of surgery PR, 
BP, SPo2. IV fluids were given according to Body weight, blood loss and 3rd 
space loss.  
 Injection Diclofenac sodium 75 mg IV infusion was started after one 
hour of surgery for both groups. Fentanyl supplements of 20µg were used as 
and when necessary. 
 At the end of surgery after replacing blood losses and fluids and after 
recovery from muscle relaxants by clinical assessment,  patient was reversed 
with inj. Neostigmine 0.05 mg/kg + Glycopyrolate 10µg/Kg i.v. After thorough 
suctioning and good respiratory attempts patient was extubated on table if 
hemodynamically stable. 
 Then patient was shifted to post anaesthetic care unit (PACU) with 
oxygen supplementation. PACU PG & PACU consultant were in charge of 
monitoring pain scores and further analgesic intervention as per PACU 
protocols. 
 In PACU patient all vital parameters were recorded, oxygen by Hudson 
mask 4 litre / minutes was given, and 30° Head up was given. 
 The degree of pain was assessed by visual analog scale (VAS). In PACU 
V.A.S. was done every hour until '4' hour and thereafter every '2' hours for 24 
hours. 
 VAS was also noted whenever patient complained of pain and injection 
diclofenac sodium 75 mg was given intramuscularly as intial  analgesic in 
Morphine group. Still if VAS>4 Rescue analgesic was used in the form of 
titrated boluses of Fentanyl 20µg/kg and it was titrated to patients response. 
 In control group,  inj. diclofenac 75 mg Im b.d. and inj.Tramadol 100 
mg i.v. t.d.s was given routinely as per PACU Protocol. If VAS of control > 4 
then Rescue analgesic inj. Fentanyl 20 µg boluses were given, titrated to patient 
responses. 
 Recovery characteristics include VAS score; Ramsay sedation scale, 
Postoperative HR, BP. Saturation, complications and adverse effects of opioids 
were monitored and noted.  
The other parameters monitored in the post-operative period included 
 Time for Ist demand analgesia,  
 No. of Analgesia doses in Ist 24 hours 
 No. of NSAID doses in Ist 24 hours 
 No. of Rescue analgesic does in 24 hour . 
The complications monitored included 
1. Retention of urine is common after spinal opioids but all our cases 
patients were catheterized and hence it was not evaluated. 
2. Respiratory depression. It is defined as a respiratory rate < 8 / min and 
or oxygen saturation < 90%. This was planned to be managed with bag 
and make ventilation or intubation and I.P.P.V. if necessary naloxone 
0.1 mg intravenously administered every 5-10 minutes till normal 
breathing pattern was established. 
3. Nausea and vomiting 
 Patients were observed for nausea and vomiting vomiting was managed 
with inj. ondansetron 8 mg intravenously. 
4. Pruritis: If distressing , it was planned to be treated with Inj. 
Promethazine 25 mg Intravenously. 
5. Hypotension was defined as systolic blood pressure < 90 mm of Hg of 
fall in systolic pressure > 30% from baseline. This was planned to be 
managed with intravenous Ephedrine in increments of 6 mg. 
6. Bradycardia : It was defined as heart rate less than 60 beats per minutes 
and this was planned to be managed with inj. Atropine 0.01 mg/kg 
intravenously  
7. Sedation 
 The level of sedation was scored according to the six grade score 
devised by Ramsay and colleagues. 
 1. Anxious and agitated or restless or both. 
 2. Cooperative oriented and tranquil 
 3. Responds to commands only 
 4. Asleep with brisk response to light glabellar tap or loud auditory 
stimulus. 
 5. Asleep with sluggish response to stimulus. 
 6. Asleep with no response to stimulus. 
 A sedation score greater than '4' was considered significant. Patient was 
observed for 24 hours then if hemodynamically stable then patients was 
shifted to postoperative ward for continued care. Patient study was 
completed after 24 hours of intrathecal morphine. 
Study 
 A total of 50 cases each were randomly allocated to one of the 
following, two groups viz Group – M(Morphine) and Group - C 
(Control).The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2002). 
 Using this software, frequencies, percentages, means, standard 
deviations, chi square and  'p'  values were calculated. Kruskul Wallis chi-
square  test was used to test the significance of difference between quantitative 
variables and Yate’s test for qualitative variables. A 'p' value less than 0.05 is 
taken to denote significant relationship. 
OBSERVATION & RESULTS 
 The study was conducted at Government General Hospital, Chennai. 
Fifty patients were included in this double blind randomized control study. 
 The patients were divided into two groups of twenty-five each, patients 
in Group-M received intrathecal Morphine 0.5 mg in '1' ml at L3 - L4 interspace 
and routine General anesthesia and Group - C received only balanced General 
anaesthesia followed by multimodal analgesia protocol followed at the institute 
which consisted of a combination of analgesic Inj.Tramadol hydrochloride plus 
Inj. Diclofenac Sodium. Rescue Analgesic in the form of titrated boluses of 
Fentanyl Citrate was used as and when required to meet titrated end points 
based on VAS scores. 
Demographic Data : 
Table 1 : Age 
Morphine  Group Control Group 
Age Group 
No % No % 
Up to 20 Yrs 1 4 1 4 
21-30 5 20 7 28 
31-40 6 24 6 24 
41-50 7 28 5 20 
51-60 3 12 5 20 
Above 60 years 3 12 1 4 
Total 25 100 25 100 
Mean 41.0 Years 39.2 Years 
SD 13.8 Years 12.6 Years 
‘p’ 0.6835  Not Significant 
 
 Both the groups were comparable with respect to age, height, weight, 
baseline pulse rate, systolic and diastolic blood pressure, respiratory rate and 
oxygen saturation. The duration of surgery was also comparable between the 
two groups. This was not statistically significant  between the groups in 
demographic aspect. 
Table 2 : Sex 
Morphine Group Control Group 
Sex 
No % No % 
Male 14 56 15 60 
Female 11 44 10 40 
Total 25 100 25 100 
‘p’ 0.7767  Not Significant 
 
 There were 14 males, 11 females in Morphine group and in control 
group were 15 males and 10 females, and it was not significant which has P 
value 0.7767. The time for Ist demand analgesia in the postoperative period in 
Group-M is 13.8hours and in Group–C 1.0 hour and statistically 
significant.(p=0.00079) 
 
Table  3: Analgesic requirements  
 
Morphine Group Control Group  
Drug use 
No. % No. % 
 
‘p’ 
Time for Ist PT analgesic 
demand (in hours) 
13.8 11.9 1.0 1.0 0.0079 
Significant
Number of analgesic 
demand in 24 hours 
1.56 2.31 4.2 2.93 0.0002 
Significant 
Total NSAID used in  
24 hours 
0.44 0.51 - - - 
Inj. Fentanyl used in  
24 hours((µg) 
1.1 1.94 86 72.6 0.0003 
Significant
 The number of demand analgesic in 24 hours is 1.56 in group-M vs 4.2 
in group-C and it is statistically significant (p=0.0002) 
 The total rescue analgesic inj. Fentanyl used in group-m is 1.1 vs. 86 in 
group-c and it is statistically significant. (p=0.0003). 
Table 4 : Intra Operative systolic B.P. 
 
Morphine. 
Group Control Group 
Intra 
Operative 
Systolic 
B.P at 
minutes 
Mean S.D Mean S.D 
p Significance 
Baseline 124 17.9 125.1 17.7 0.7729 Not Significant 
15 123 16.4 122.4 14.8 0.7993 Not Significant 
30 119 17.1 121.5 15.5 0.4504 Not Significant 
45 123 16.1 119.2 15.1 0.4467 Not Significant 
60 120 14.7 122.9 12.8 0.4115 Not Significant 
75 120 14.0 121.4 14.4 0.9753 Not Significant 
90 116 15.5 122.3 13 0.1206 Not Significant 
105 117 9.7 121.9 13.7 0.3503 Not Significant 
120 117 16.1 119.1 14.3 0.6378 Not Significant 
135 118 12.5 121.0 14.4 0.4647 Not Significant 
150 120 11.9 119.4 13.4 0.7943 Not Significant 
165 117 12 118 14.1 0.7559 Not Significant 
180 117 16 117.6 13.4 0.8157 Not Significant 
 
 The mean intraoperative systolic BP was 124 in Morphine group and 
125 in control group and statistically not significant.  
Table 5 : Intra Operative Diastolic B.P. 
 
Morphine group Control group Intra 
Operative 
D.B.P. at 
minutes Mean S.D Mean S.D 
p Significance 
Baseline 80.1 7.9 82.8 10.8 0.3901 Not Significant 
15 80.2 10.0 81.3 12.1 0.7699 Not Significant 
30 78.0 11.3 80.3 10.4 0.3404 Not Significant 
45 77.8 9.9 79.5 12.6 0.4892 Not Significant 
60 77.2 8.6 82.5 11.7 0.1019 Not Significant 
75 76.8 9 82.0 9.7 0.1046 Not Significant 
90 75.3 9.3 81.4 8.3 0.0114 Significant 
105 76.4 8.1 79.3 9.3 0.3937 Not Significant 
     120 76.5 11.2 78.7 8.4 0.7631 Not Significant 
135 79.2 7.5 80.4 9.4 0.5076 Not Significant 
150 78 7.9 81.2 9.4 0.1445 Not Significant 
165 76.7 7.4 78.6 9.6 0.3202 Not Significant 
180 77.2 8.4 78.8 9.0 0.4659 Not Significant 
 
 Intra operative diastolic Blood pressure was compared between both 
groups  had 80 and control group 82 and P value as 0.39 and not significant. 
Table 6 : Intra Operative  Mean Arterial B.P. 
 
 
Morphine group Control group Intra Operative 
MAP at 
minutes Mean S.D. Mean S.D. 
p Significance 
Baseline 94.6 10.2 96.9 12.6 0.5527 Not Significant 
15 95.0 11.7 95 12.6 0.9923 Not Significant 
30 92.3 12.9 94 11.3 0.3366 Not Significant 
45 92.9 11.1 92.8 12.9 0.8842 Not Significant 
60 92.4 9.7 96 11.1 0.1564 Not Significant 
75 91.3 9.4 95.1 9.9 0.1679 Not Significant 
90 89 10.3 95 9.1 0.0262 Significant 
105 90 7.9 93.5 9.6 0.3035 Not Significant 
120 90.1 12.2 92.2 9.4 0.5473 Not Significant 
135 92.4 8.1 93.9 10.7 0.5409 Not Significant 
150 92.2 8.2 93.9 10.2 0.4093 Not Significant 
165 90.4 7.9      91.8 10.5 0.4847 Not Significant 
180 90.5 9.8 91.8 9.8 0.8008 Not Significant 
 
 
 The mean arterial pressure is not significant between both groups and 
group-M had 94 ± 10.8 and in  group-C 96 ± 12.6 and P value 0.5527.  But is 
significant at 90th minute (P = 0.0262). Probably it is associated with   onset of 
action of IT morphine.  
Table 7 : Intra Operative pulse Rate 
 
 
Intra Operative Pulse Rate 
 
Morphine group Control group 
Intra 
Operative 
PR 
at 
minutes Mean S.D Mean S.D 
p Significance 
0 90 14.8 91.2 16.9 0.7924 Not Significant 
15 91.5 17.0 91.3      19.1 0.5998 Not Significant 
30 90.8 16.5 88.9 14.3 0.734 Not Significant 
45 88 16.7 89.1 16.7 0.7634 Not Significant 
60 88.2 17.3 87.4 19.3 0.7633 Not Significant 
75 85.8 16.7 85.8 19.5 0.9227 Not Significant 
90 85.1 18.2 83.3 17.2 0.969 Not Significant 
105 83.5 20.3 81.1 17.3 0.8536 Not Significant 
120 84 21.5 79.4 16.0 0.4374 Not Significant 
135 86.8 21.7 78.3 16.4 0.1508 Not Significant 
150 86.3 22.1 79.6 16.2 0.2989 Not Significant 
165 86.6 22 80.1 16.2 0.3983 Not Significant 
180 83.5 19.2 82.8 16.9 0.9768 Not Significant 
 
 
 Intra operative pulse rate in group –M was 90 ± 14 Vs 91 ± 16.9 in 
group-C and it is statistically not significant.  
 
 
 
 
Table 8: Post Operative VAS 
 
M Group Control Group Post Op. 
Vas at 
hours Mean SD Mean SD 
‘p’ Significance 
0 hours 4.64 1.41 5.0 1.41 0.3448 Not Significant 
2 hours 4.64 1.41 5.24 0.88 0.0751 Not Significant 
4 hours 3.76 0.88 4.6 0.76 0.0009 Significant 
8 hours 3.8 0.76 4.4 0.76 0.0055 Significant 
10 hours 3.8 0.71 3.92 0.49 0.2868 Not Significant 
12 hours 3.6 0.58 4.04 0.61 0.0137 Significant 
14 hours 3.72 0.54 3.76 0.66 0.9177 Not Significant 
16 hours 3.84 0.47 3.96 0.45 0.3609 Not Significant 
18 hours 3.84 0.47 3.88 0.53 0.8 Not Significant 
20 hours 3.84 0.47 4.08 0.76 0.199 Not Significant 
22 hours 3.88 0.44 4.4 0.65 0.0017 Significant 
24 hours 3.92 0.49 3.84 0.55 0.5704 Not Significant 
 
 Post operative visual analog score in Group-M was 4.64 vs 5 in  group-
C. But it was highly significant at 2, 4, 8, 12, 20 Hours and. However,   it was 
not significant at postoperative zero hour, 14, 16, 24 hours. Intrathecal 
Morphine seems to have a certain lag in onset of analgesia. 
    
 
Table 9 : Post Operative RSS 
 
 
Morphine Group Control Group Post Op.  
RSS at 
hours Mean SD Mean SD 
‘p’ Significance
0 2.16 0.8 1.6 0.76 0.0156 Significant 
2 2.32 0.47 1.56 0.65 0.0001 Significant 
4 2.28 0.46 1.56 0.58 0.0001 Significant 
6 2.32 0.48 1.68 0.56 0.0002 Significant 
8 2.28 0.46 1.68 0.56 0.0003 Significant 
10 2.24 0.52 1.88 0.44 0.0124 Significant 
12 2.24 0.44 1.92 0.4 0.0113 Significant 
14 2.24 0.44 2.0 0.29 0.0281 Significant 
16 2.24 0.44 2.04 0.2 0.0437 Significant 
18 2.32 0.48 2.04 0.2 0.0107 Significant 
20 2.36 0.49 2.04 0.2 0.0051 Significant 
22 2.32 0.48 2.04 0.2 0.0107 Significant 
24 2.28 0.46 2.04 0.2 0.0219 Significant 
 
 
 Postoperative Ramsay sedation scale is 2.16 in Group-M, 1.6 in  
Group-C,  This is statistically significant (P - 0.0156). 
 
 
 
 
 
 
 
Table 10 : Post Operative Heart  Rate 
 
 
Morphine Group Control Group Post Op. Heart 
rate at 
hours Mean SD Mean SD 
‘p’ Significance 
0 85 12.7 101 13.9 0.0002 Significant 
2 80 10.2 100 11.4 0.0001 Significant 
4 76 9.8 99 12.2 0.0001 Significant 
8 76 11.3 99 10 0.0001 Significant 
12 79 11.5 99 11.3 0.0001 Significant 
16 78 9.1 100 10.1 0.0001 Significant 
20 78 8.2 100 9.6 0.0001 Significant 
24 77 8.5 102 8.8 0.0001 Significant 
 
 
 The postoperative heart rate was in group-M Vs group -C are 85±12.7 
and 101 ± 13.9 respectively and it is statistically significant (P=0.0002) during 
the postoperative period. The Postoperative changes in heart rate are significant 
at 2, 4, 8 and 24 hours after intrathecal Morphine injection. 
 
 
 
 
 
 
 
 
 
Table 11:  Post Operative Systolic B.P 
 
 
Morphine Group Control Group Post Op. 
SBP at 
hours Mean SD Mean SD 
‘p’ Significance
0 116 23.4 138.7 22.2 0.0018 Significant 
2 113.0 21.6 135.2 22.2 0.0033 Significant 
4 111.3 22.2 140.3 17.5 0.0001 Significant 
8 109 22.4 142.4 16.3 0.0001 Significant 
12 110.4 20.5 141.5 18.1 0.0001 Significant 
16 109.2 19.8 138.4 18.4 0.0001 Significant 
20 107.5 18.4 139.8 18.7 0.0001 Significant 
24 107.2 17.0 137.8 17.2 0.0001 Significant 
 
 
 Post operative systolic BP was 116 ± 23.4 in Group - M Vs 138 ± 22 in 
control group which is statistically significant p = 0.0018. 
 
 
 
 
 
 
 
 
Table 12 : Post Operative Diastolic B.P. 
 
 
M Group Control Group Post Op. 
DBP at 
hours Mean SD Mean SD 
‘p’ Significance
0 75.4 12.7 87.1 11.7 0.0019 Significant 
2 76 13.7 85.8 9.4 0.0145 Significant 
4 73.9 13.2 86.6 8.3 0.001 Significant 
8 72.9 12.3 89 9.8 0.0001 Significant 
12 73.3 11.1 88.1 9.4 0.0001 Significant 
16 72 9.8 87.1 7.5 0.0001 Significant 
20 71.2 10.2 86.6 8.4 0.0001 Significant 
24 71 9.6 85 6.3 0.0001 Significant 
 
 
 Post operative Diastolic BP was 75.4 ± 12.7 in Group - M Vs  
87.1 ± 11.7 in control group which is statistically significant p = 0.0019. 
 
 
 
 
 
 
 
 
Table 13 :  Post Operative MAP 
 
 
Morphine Group Control Group Post Op. 
MAP at 
hours Mean SD Mean SD 
‘p’ Significance
0 89 15.7 104 14.3 0.0012 Significant 
2 88 16.1 102 12.4 0.0049 Significant 
4 86 15.9 104 10.1 0.0002 Significant 
8 85 15.3 107 10.9 0.0001 Significant 
12 86 13.9 106 10.8 0.0001 Significant 
16 84 12.4 104 10.1 0.0001 Significant 
20 83 12.4 104 10.3 0.0001 Significant 
24 83 11.7 103 8.8 0.0001 Significant 
 
 
 The postoperative mean arterial pressure (MAP) is 89 ±15.7 Vs  
104 ± 14.3 which is statistically significant (P = 0.0012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14 : Complications 
 
Morphine Group Control Group  
Complications No. % No. % 
Nausea 11 44 9 36 
Vomiting 11 44 9 36 
Respiratory Depression 3 12 - - 
Pruritis 11 44 5 20 
Desaturation 1 4 - - 
Hypotension 3 12 - - 
Bradycardia 2 8 - - 
Total cases with complications 19 76 12 48 
Total cases without 
complications 
6 24 13 52 
‘p’ 0.0804 
Not significant 
 
There was no statically significant difference in the complications 
between the 2 groups. However Nausea & Vomitting was more in the IT 
Morphine group ( 11 vs. 9). Desaturation, Pruritis, bradycardia and hypotension 
was also more in the morphine group. These findings may be clinically relevant 
although statistical analysis did not reveal any significant difference. 
 
  
DISCUSSION 
 The  randomized prospective study  was conducted at Government 
General Hospital, Chennai to study the efficacy of  intrathecal Morphine 0.5 
mg in '1' ml with General anesthesia versus only balanced General anaesthesia 
followed by multimodal analgesia protocol followed at the institute with 
respect to intra-operative and post-operative analgesia, Hemodynamics and 
complications in the two groups. 
ANALGESIA 
 Post operative visual analog score in Group-M was 4.64 vs 5 in  group-
C. But it was highly significant at 2, 4, 8, 12, 20 Hours and  it was not 
significant at postoperative zero hour, 14, 16, 24 hours. Intrathecal Morphine 
seems to a superior post-operative analgesia effect.  
 Kwan As, Lee BB, Brake T  showed the median pain free period in 
prolonged (ie 16-24 hrs) in IT morphine group compared with control group (2-
24 hrs).  Our study is in concurrence with this study. 
 Gwirtz KH, Young JV, Byers RS, Alley C, Levin K, Walker SG, 
Stoelting RK found in their retrospective study intrathecal morphine  analgesia 
was superior for acute postoperative pain in  5969 surgical patients studied at 
Indiana University Hospital undergoing  major urologic, orthopedic, general/ 
vascular, thoracic, and nonobstetrical gynecologic surgery.  The findings in our 
study are in agreement with this study. 
 Jean-Michel Devys,Anne Mora, Benoit Plaud et al in their study 
found  IT Morphine 0.4 mg in 60 adult patients undergoing major abdominal 
surgery produced  VAS scores that were lower in the IT morphine group for the 
first 48 hours, both at rest and during coughing. This is totally in agreement 
with the findings of this study. 
TIME FOR DEMAND ANALGESIA AND DOSES OF RESCUE 
ANALGESIA 
 The number of demand analgesic in 24 hours is 1.56 in group-M vs 4.2 
in group-C and it is statistically significant (p=0.0002).  The total rescue 
analgesic inj. Fentanyl used in group- M is 1.1 vs. 86 in group-C and it is 
statistically significant. (p=0.0003). 
 Jean-Michel Devys,Anne Mora, Benoit Plaud et al studied  IT 
Morphine 0.4 mg in 60 adult patients undergoing major abdominal surgery. 
Supplemental analgesia consumption was lower and  patient satisfaction higher 
in the IT Morphine group. 
 Andrew et al studied the efficacy and safety of low dose Intrathecal 
Morphine for post operative analgesia in children . The time for demand 
analgesic by  patient requiring opioid administration (Parental or oral) was 
approximately 8 hours. Our study has similar findings establishing the efficacy 
of  IT Morphine for post-operative pain relief. 
 
INTRA-OPERATIVE AND POST-OPERATIVE HAEMODYNAMICS 
 Hemodynamic parameters including SBP, DBP, MAP, HR, SaO2 were 
compared both in the intra-operative period and post-operative period. Intra-
operatively there was no difference between both the groups. Post-operatively 
IT Morphine group demonstrated sginigficantly stabler Hemodynamics. This 
may be related to the more superior and stables pain control that was achieved 
in this group. 
 ASK Kwan, BB.Lee, T.Brake et al in their study using  0.2 mg of 
preservative free morphine 0.2 mg to 2.2 ml of hyperbaric bupivacaine 2.2 ml 
in patients undergoing hip surgeries demonstrated no alterations in 
Hemodynamics both in the intra-operative and post-operative period. This 
asserted the hemodynamic stability of intrathecally used morphine. The 
findings in our study agree with these conclusions. 
POST_OPERATIVE COMPLICATIONS 
 Nausea & Vomitting was more in the IT Morphine group ( 11 vs. 9). 
Desaturation, Pruritis, bradycardia and hypotension was also more in the 
morphine group. These findings may be clinically relevant although statistical 
analysis did not reveal any significant difference. 
 Glynn CG et al [1979] and Davies GK et al [1980] reported respiratory 
depression following spinal morphine. In our study we had 2 patients with 
hypoventilation and 1 patient developed desaturation but they were easily 
manageable by oxygen supplementation. 
 Reiz and Westberg [1980] and Yaksh TL [1981] and Samii J, Chanin 
M and Viars P [1981] reported adverse reactions such as pruritus and urinary 
retention after intrathecal administration of opioids. Our study recorded Pruritis 
in patients but urinary retention could not be assessed since all patients 
continued to have their bladders catheterized during the study period. 
 Ganesh A, K.M.A. Cucchiaro studied the effect of low dose (4-
5μg/kg) intrathecal morphine and found the incidence of Nausea or vomiting, 
pruritis and urinary retention was 32%, 37% and 6% respectively. The findings 
in our study are in concurrence with these studies. 
 
 
 
 
 
 
 
 
 
SUMMARY 
 The study was conducted at Government General Hospital, Chennai on 
fifty patients to compare the effect of IT morphine ( 0.5 mg) for providing post-
operative analgesia in patients undergoing major laprotomies. The summary of 
the findings include 
 
1. Intrathecal Morphine produced better post-operative analgesia as shown 
by lower VAS scores. 
2. Intrathecal Morphine group demonstrated lesser amounts of analgesic 
and rescue analgesic requirements during the post-operative period. 
3. Intrathecal Morphine group of patients has better sedation as shown by 
better scores on the Ramsay scale. 
4. Intrathecal Morphine produced better hemodynamic stability in the post-
operative period and also was associated with lower heart rates. 
5. Intrathecal Morphine produced more side effects in the form of nausea, 
vomiting, hypotension, bradycardia and hypotension. Although not 
statistically significant  these findings seem to be clinically relevant. A 
larger sample of study may have revealed statistical significance. 
6. All the side effects produced by IT Morphine were easily manageable 
and did not contribute to any increase in mortality or morbidity. 
7. IT Morphine did not seem to produce any significant changes in the 
Hemodynamics or management of the patient during the intra-operative 
period. This may be related to the lag time for the rostral spread of the 
drug. 
8. IT Morphine is a good substitute or adjunct to various modalities used to 
offer analgesia during the post-operative period in patients undergoing 
major laprotomies 
9. IT Morphine does not require any complex procedures and or equipment 
for administration 
10. IT Morphine is a cost effective adjunct and alternative to the various 
modalities available to provide pain relief during the post- operative 
period. 
 
 
 
 
 
 
 
CONCLUSION 
 Preservative free morphine 0.5 mg administered intrathecally in patients 
undergoing laparotomies under general anesthesia  
 Provides effective analgesia during the first 24 hours of the post-
operative period. 
 It decreases the requirement of rescue analgesics during the post-
operative period. 
 It is associated with stable Hemodynamics and better levels of sedation. 
 It is associated with increased adverse effects but these are easily 
manageable by simple measures. 
INTRA OPERATIVE MEAN ARTERIAL PRESSURE 
MORPHINE GROUP 
INTRA OPERATIVE MEAN ARTERIAL PRESSURE  AT 
MINUTES 
No 
0 15 30 45 60 75 90 105 120 135 150 165 180 
1 83 84 90 84 85 82 81 86 88 87 86 80 79 
2 97 60 93 95 103 101 101 99 101 103 99 97 100 
3 97 69 85 83 87 72 85 92 81 84 85 88 82 
4 94 63 97 105 98 91 91 94 97 95 95 90 86 
5 78 57 81 76 85 82 78 74 71 76 77 81 82 
6 109 67 113 116 107 101 101 99 104 96 101 99 83 
7 113 63 88 87 83 90 91 91 94 99 95 91 89 
8 95 59 81 81 83 93 83 84 101 104 104 105 104 
9 89 87 118 117 75 72 70 85 84 86 89 86 73 
10 90 77 90 98 97 97 90 97 98 93 83 80 81 
11 80 52 79 95 103 95 88 97 96 89 91 93 92 
12 119 67 81 97 97 101 103 98 99 98 100 90 113 
13 96 70 81 91 88 97 89 87 84 83 88 81 83 
14 89 54 115 117 79 79 90 97 97 100 93 97 101 
15 82 55 114 97 105 103 120 103 118 111 105 88 83 
16 103 71 97 92 97 98 93 91 77 87 91 93 96 
17 94 65 73 81 83 109 87 101 88 84 92 95 99 
18 97 70 87 91 90 89 94 87 99 95 95 92 97 
19 95 65 89 93 110 92 84 89 95 96 90 93 96 
20 97 65 84 80 97 99 96 88 89 89 89 86 92 
21 85 89 87 83 81 85 81 81 81 94 100 100 90 
22 83 53 93 87 80 81 73 82 70 90 80 72 78 
23 107 63 83 88 90 93 81 73 70 83 77 85 86 
24 97 73 97 93 89 88 87 91 98 100 107 101 100 
25 97 67 113 97 94 93 89 83 73 87 92 97 99 
 
 
INTRA OPERATIVE MEAN ARTERIAL PRESSURE 
CONTROL GROUP 
INTRA OPERATIVE MEAN ARTERIAL PRESSURE  AT MINUTES 
No 
0 15 30 45 60 75 90 105 120 135 150 165 180 
1 117 71 98 107 107 109 107 110 103 103 105 100 95 
2 99 77 100 97 102 93 99 111 91 104 87 91 94 
3 99 72 91 81 81 87 91 91 91 93 97 98 99 
4 95 67 80 87 95 95 97 96 86 94 93 93 96 
5 120 79 103 103 106 111 113 112 100 107 110 109 103 
6 83 61 87 79 82 84 84 83 81 80 79 71 77 
7 83 47 86 70 83 76 86 83 79 74 73 71 73 
8 103 71 120 103 99 97 99 97 93 93 93 91 90 
9 77 63 84 81 83 83 84 84 79 79 81 83 80 
10 91 82 93 91 109 107 105 103 98 94 95 92 89 
11 120 69 87 101 96 103 91 88 101 107 101 107 90 
12 96 59 90 83 105 97 100 95 97 96 92 95 97 
13 99 58 105 90 101 106 103 90 100 87 98 102 111 
14 95 79 96 99 105 108 107 105 97 100 92 78 78 
15 83 53 77 83 80 83 90 89 90 94 91 87 85 
16 95 57 79 84 91 83 83 83 81 95 97 91 91 
17 97 77 105 106 82 97 83 76 77 77 80 82 79 
18 97 67 99 102 105 104 97 96 101 103 103 105 98 
19 93 64 83 87 87 83 93 89 89 85 90 84 95 
20 97 83 98 112 109 105 104 100 112 114 112 102 101 
21 97 53 99 107 91 94 103 99 94 107 98 101 110 
22 77 60 83 76 85 97 82 83 83 81 80 77 83 
23 93 57 97 91 104 97 83 100 107 97 111 97 91 
24 90 63 90 79 91 84 92 88 85 85 93 90 95 
25 126 102 121 121 121 95 101 87 89 100 99 97 96 
 
POST OPERATIVE MEAN ARTERIAL PRESSURE 
MORPHINE GROUP 
INTRA OPERATIVE MEAN ARTERIAL PRESSURE  AT HOURS 
No 
0 2 4 8 12 16 20 24 
1 89 95 87 93 92 80 80 80 
2 93 70 71 70 74 74 71 73 
3 109 108 105 114 112 97 99 97 
4 101 97 86 67 73 73 80 80 
5 80 73 73 74 76 76 73 73 
6 104 107 107 101 97 98 100 93 
7 96 97 98 97 98 97 93 93 
8 70 71 70 70 71 70 70 71 
9 113 117 110 107 108 105 105 109 
10 80 90 70 77 80 95 81 81 
11 91 87 87 90 84 77 78 77 
12 70 71 71 70 70 70 71 71 
13 80 79 79 80 81 80 80 80 
14 73 70 71 71 73 77 78 75 
15 107 108 105 99 102 99 97 95 
16 75 77 70 77 78 76 74 78 
17 72 73 72 70 71 71 70 70 
18 77 75 75 68 71 75 67 69 
19 120 115 117 107 107 107 107 105 
20 80 80 80 79 79 80 79 79 
21 105 107 108 96 97 98 101 99 
22 71 70 70 70 70 71 70 70 
23 93 89 92 93 95 83 83 83 
24 107 108 107 108 104 101 93 93 
25 70 77 77 75 79 80 80 80 
 
POST OPERATIVE MEAN ARTERIAL PRESSURE 
CONTROL GROUP 
INTRA OPERATIVE MEAN ARTERIAL PRESSURE  AT HOURS 
No 
0 2 4 8 12 16 20 24 
1 98 95 97 96 96 99 99 95 
2 83 79 96 97 98 100 91 97 
3 76 83 89 83 83 83 83 90 
4 107 107 99 108 103 103 100 100 
5 101 107 105 107 101 104 104 101 
6 116 95 111 126 123 123 119 110 
7 117 107 106 108 113 113 120 117 
8 107 107 101 117 117 115 113 108 
9 115 101 101 101 96 99 87 88 
10 103 105 112 115 114 107 106 98 
11 101 94 93 93 97 89 99 93 
12 103 100 99 100 94 95 93 98 
13 123 122 121 127 117 114 109 107 
14 117 120 115 111 114 111 110 119 
15 82 98 98 98 110 101 99 99 
16 107 104 112 113 108 108 123 95 
17 115 113 111 108 106 99 102 101 
18 113 104 101 97 100 93 97 99 
19 70 76 83 99 105 107 99 99 
20 107 107 108 121 92 95 105 105 
21 95 93 90 99 97 93 98 95 
22 100 90 108 103 100 105 110 106 
23 107 110 121 113 122 117 113 115 
24 127 122 117 115 117 118 110 115 
25 118 117 116 119 124 116 119 115 
 
COMPLICATIONS MASTER CHART 
 
MORPHINE GROUP 
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1 24 0   0 0 Yes Yes No No No No No 
2 24 0   0 0 No No No Yes No No No 
3 0 2   1 1 No No No Yes No No No 
4 24 0   0 0 Yes Yes No Yes No Yes No 
5 24 0   0 0 No No No Yes No No No 
6 0 2   1 1 Yes Yes No No No No No 
7 0 5   1 4 No No No No No No No 
8 10 2   1 1 No No No Yes No No Yes 
9 0 3   1 2 No No Yes No No No No 
10 24 0   0 0 No No No No No No No 
11 24 0   0 0 Yes Yes No Yes No No No 
12 24 0   0 0 No No No No No No No 
13 24 0   0 0 No No No No No No No 
14 24 0   0 0 Yes Yes No Yes No No No 
15 0 6   1 5 Yes Yes No No No No No 
16 0 4   1 3 No Yes Yes No No Yes Yes 
17 24 0   0 0 No No No No No No No 
18 24 0   0 0 No No No Yes No No No 
19 0 5   1 4 Yes Yes No No No Yes No 
20 24 0   0 0 Yes Yes No No No No No 
21 0 8   1 7 No No No Yes No No No 
22 24 0   0 0 No No No Yes No No No 
23 0 1   1 0 No No No No No No No 
24 0 1   1 0 Yes Yes Yes No No No No 
25 24 0   0 0 Yes Yes No Yes No No No 
 
NSAID - Inj. Diclofenac 75 mg 
 
COMPLICATIONS MASTER CHART 
 
CONTROL GROUP 
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1 0 7 DT   150 No No No No No No No 
2 0 7 DT   150 No No No No No No No 
3 0 3 DT   50 Yes Yes No Yes No No No 
4 0 5 DT   100 Yes Yes No Yes No No No 
5 2 1 DT   0 No No No No No No No 
6 2 1 DT   0 Yes Yes No No No No No 
7 2 1 DT   0 No No No Yes No No No 
8 2 1 DT   0 No No No No No No No 
9 0 8 DT   175 No No No No No No No 
10 0 7 DT   150 No No No No No No No 
11 2 4 DT   75 No No No No No No No 
12 0 7 DT   150 No No No No No No No 
13 2 6 DT   125 Yes Yes No No No No No 
14 0 8 DT   175 No No No No No No No 
15 2 1 DT   0 No No No Yes No No No 
16 2 3 DT   50 No No No No No No No 
17 0 6 DT   125 Yes Yes No No No No No 
18 2 1 DT   0 Yes Yes No No No No No 
19 0 7 DT   150 No No No Yes No No No 
20 2 1 DT   0 No No No No No No No 
21 2 1 DT   0 Yes Yes No No No No No 
22 0 7 DT   150 Yes Yes No No No No No 
23 0 9 DT   200 Yes Yes No No No No No 
24 2 2 DT   25 No No No No No No No 
25 0 1 DT   150 No No No No No No No 
 
 
 
 
  
 
 
 
 
 
SPINAL SITE OF ACTION OF OPIOIDS 
 
 
 
 
 
 
 
 
 
VISUAL ANALOG SCALE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROFORMA 
 
NAME :     ASA STATUS : 
AGE / SEX:     HEIGHT : 
DIAGNOSIS :    WEIGHT : 
SURGERY :     BMI : 
PRE OP ASSESMENT   INVESTIGATIONS : 
1.AIRWAY :     Hb.&PCV : 
2,BACK LANDMARKS   BT , CT 
3.COMORBID ILLNESS   BLOOD        SUGAR 
      UREA 
                SERUM CREATININE  
       ELECTROLYTES 
PREMED: 
IV ACCESS: 18 G 
PRELOAD FLUID VOLUME 
RL / NS 500ML 
   
SUBARACHNOID BLOCK 
SPACE NEEDLE SIZE APPROACH 
L 3,4 QUINCKIE 25 G MEDIAN 
  
GROUP MORPHINE CONTROL TOTAL 
VOLUME 
 0.5mg NONE 1cc 
 
 
GENERAL ANAESTHESIA : 
Premedication: inj. Glycopyrrolate 0.2 mg + Fentanyl 2µg / Kg 
Pre oxygenation with 100% O2 for 3 min. 
Induction : Inj. Thiopentone 5mg/Kg + suxamethonium 2mg /kg. 
Intubation with 8 /8.5 CETT orally. 
Maintenance N2O –O2 :150  
Relaxant  :        Vecuronium 0.12 mg /kg   
Reversal  : Inj. Neostigmine 2.5 mg + Glycopyrrolate 0.4 mg. 
Extubation : 
Intra op vitals: 
TIME 0 15 
min 
30 
min 
45 
min 
1 
hr 
1.15 1.30 1.45 2 2.15 2.30 2.45 3 
PR              
BP              
SPO2              
 
POST OP : Patient shifted to PACU for observation. 
Recovery : 
TIME 0 2 4 6 8 10 12 16 20 24 
VAS           
RSS           
PR           
SPO2           
BP           
 
 
 Complications YES /NO Interventions Needed 
1. PRURITIS 
2. NAUSEA 
3. VOMITING 
4. RESPIRATORY 
DEPRESION 
5. RETENTION OF 
URINE 
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